• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

开发和验证一种列线图,用于预测韩国人群的肺功能和慢性阻塞性肺疾病的存在。

Development and validation of a nomogram to predict pulmonary function and the presence of chronic obstructive pulmonary disease in a Korean population.

机构信息

Division of Pulmonology, Department of Internal Medicine, National Health Insurance Service Ilsan Hospital, Goyang, Republic of Korea.

Research Institute, National Health Insurance Service Ilsan Hospital, Goyang, Republic of Korea.

出版信息

BMC Pulm Med. 2021 Jan 19;21(1):32. doi: 10.1186/s12890-021-01391-z.

DOI:10.1186/s12890-021-01391-z
PMID:33468128
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7816387/
Abstract

BACKGROUND

Early suspicion followed by assessing lung function with spirometry could decrease the underdiagnosis of chronic obstructive pulmonary disease (COPD) in primary care. We aimed to develop a nomogram to predict the FEV/FVC ratio and the presence of COPD.

METHODS

We retrospectively reviewed the data of 4241 adult patients who underwent spirometry between 2013 and 2019. By linear regression analysis, variables associated with FEV/FVC were identified in the training cohort (n = 2969). Using the variables as predictors, a nomogram was created to predict the FEV/FVC ratio and validated in the test cohort (n = 1272).

RESULTS

Older age (β coefficient [95% CI], - 0.153 [- 0.183, - 0.122]), male sex (- 1.904 [- 2.749, - 1.056]), current or past smoking history (- 3.324 [- 4.200, - 2.453]), and the presence of dyspnea (- 2.453 [- 3.612, - 1.291]) or overweight (0.894 [0.191, 1.598]) were significantly associated with the FEV/FVC ratio. In the final testing, the developed nomogram showed a mean absolute error of 8.2% between the predicted and actual FEV/FVC ratios. The overall performance was best when FEV/FVC < 70% was used as a diagnostic criterion for COPD; the sensitivity, specificity, and balanced accuracy were 82.3%, 68.6%, and 75.5%, respectively.

CONCLUSION

The developed nomogram could be used to identify potential patients at risk of COPD who may need further evaluation, especially in the primary care setting where spirometry is not available.

摘要

背景

在初级保健中,通过早期怀疑和肺功能测定(如肺活量测定)可以减少慢性阻塞性肺疾病(COPD)的漏诊。我们旨在开发一个列线图来预测 FEV/FVC 比值和 COPD 的存在。

方法

我们回顾性分析了 2013 年至 2019 年间接受肺活量测定的 4241 例成年患者的数据。通过线性回归分析,在训练队列(n=2969)中确定了与 FEV/FVC 相关的变量。使用这些变量作为预测因子,创建了一个列线图来预测 FEV/FVC 比值,并在测试队列(n=1272)中进行验证。

结果

年龄较大(β系数[95%CI],-0.153[-0.183,-0.122])、男性(-1.904[-2.749,-1.056])、当前或既往吸烟史(-3.324[-4.200,-2.453])以及呼吸困难(-2.453[-3.612,-1.291])或超重(0.894[0.191,1.598])与 FEV/FVC 比值显著相关。在最终的测试中,开发的列线图在预测和实际 FEV/FVC 比值之间的平均绝对误差为 8.2%。当 FEV/FVC<70% 被用作 COPD 的诊断标准时,该列线图的整体性能最佳;其灵敏度、特异性和平衡准确性分别为 82.3%、68.6%和 75.5%。

结论

该列线图可用于识别可能需要进一步评估的潜在 COPD 风险患者,尤其是在无法进行肺活量测定的初级保健环境中。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/945b/7816387/915b7545ddee/12890_2021_1391_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/945b/7816387/1dd3cca9c9ea/12890_2021_1391_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/945b/7816387/b3cf07800251/12890_2021_1391_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/945b/7816387/915b7545ddee/12890_2021_1391_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/945b/7816387/1dd3cca9c9ea/12890_2021_1391_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/945b/7816387/b3cf07800251/12890_2021_1391_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/945b/7816387/915b7545ddee/12890_2021_1391_Fig3_HTML.jpg

相似文献

1
Development and validation of a nomogram to predict pulmonary function and the presence of chronic obstructive pulmonary disease in a Korean population.开发和验证一种列线图,用于预测韩国人群的肺功能和慢性阻塞性肺疾病的存在。
BMC Pulm Med. 2021 Jan 19;21(1):32. doi: 10.1186/s12890-021-01391-z.
2
Detection of COPD in a high-risk population: should the diagnostic work-up include bronchodilator reversibility testing?高危人群中慢性阻塞性肺疾病的检测:诊断检查应包括支气管扩张剂可逆性测试吗?
Int J Chron Obstruct Pulmon Dis. 2015 Feb 23;10:407-14. doi: 10.2147/COPD.S76047. eCollection 2015.
3
Cut-off value of FEV1/FEV6 as a surrogate for FEV1/FVC for detecting airway obstruction in a Korean population.在韩国人群中,使用FEV1/FEV6作为FEV1/FVC的替代指标来检测气道阻塞的截断值。
Int J Chron Obstruct Pulmon Dis. 2016 Aug 19;11:1957-63. doi: 10.2147/COPD.S113568. eCollection 2016.
4
Vital capacity and COPD: the Swedish CArdioPulmonary bioImage Study (SCAPIS).肺活量与慢性阻塞性肺疾病:瑞典心肺生物影像研究(SCAPIS)
Int J Chron Obstruct Pulmon Dis. 2016 May 2;11:927-33. doi: 10.2147/COPD.S104644. eCollection 2016.
5
Prevalence of colorectal adenomatous polyps in patients with chronic obstructive pulmonary disease.慢性阻塞性肺疾病患者结直肠腺瘤性息肉的患病率
Int J Chron Obstruct Pulmon Dis. 2015 May 18;10:955-60. doi: 10.2147/COPD.S83341. eCollection 2015.
6
Multicenter study of the COPD-6 screening device: feasible for early detection of chronic obstructive pulmonary disease in primary care?慢性阻塞性肺疾病-6筛查设备的多中心研究:在初级保健中早期检测慢性阻塞性肺疾病是否可行?
Int J Chron Obstruct Pulmon Dis. 2017 Aug 4;12:2323-2331. doi: 10.2147/COPD.S136244. eCollection 2017.
7
Development and validation of the Salzburg COPD-screening questionnaire (SCSQ): a questionnaire development and validation study.《萨尔斯堡 COPD 筛查问卷(SCSQ)的制定和验证》:一项问卷制定和验证研究。
NPJ Prim Care Respir Med. 2017 Jan 26;27(1):4. doi: 10.1038/s41533-016-0005-7.
8
Characteristics and self-rated health of overlap syndrome.重叠综合征的特征与自评健康状况
Int J Chron Obstruct Pulmon Dis. 2014 Jul 21;9:795-804. doi: 10.2147/COPD.S61093. eCollection 2014.
9
Determination of the efficacy of FEV6 as a surrogate for FVC in the diagnostic screening for chronic obstructive pulmonary disease through the comparison of FEV1/FVC and FEV1/FEV6 ratios.通过比较FEV1/FVC和FEV1/FEV6比值,确定FEV6作为慢性阻塞性肺疾病诊断筛查中FVC替代指标的有效性。
J Bras Pneumol. 2007 Mar-Apr;33(2):148-51. doi: 10.1590/s1806-37132007000200008.
10
Factors associated with inadequate diagnosis of COPD: On-Sint cohort analysis.慢性阻塞性肺疾病(COPD)诊断不足的相关因素:On-Sint队列分析。
Int J Chron Obstruct Pulmon Dis. 2015 May 18;10:961-7. doi: 10.2147/COPD.S79547. eCollection 2015.

引用本文的文献

1
Nomogram model of mortality risk in patients with chronic obstructive pulmonary disease in intensive care unit: based on MIMIC-IV database and external validation study.重症监护病房中慢性阻塞性肺疾病患者死亡风险的列线图模型:基于MIMIC-IV数据库及外部验证研究
Front Med (Lausanne). 2025 Jul 22;12:1547047. doi: 10.3389/fmed.2025.1547047. eCollection 2025.
2
The burden of depressive disorder among the global 10-24 age group and the construction of an early risk factors model.全球10-24岁年龄组中抑郁症的负担及早期风险因素模型的构建
Front Psychiatry. 2025 Jun 16;16:1594074. doi: 10.3389/fpsyt.2025.1594074. eCollection 2025.
3

本文引用的文献

1
Machine learning prediction for mortality of patients diagnosed with COVID-19: a nationwide Korean cohort study.基于全国韩国队列研究的 COVID-19 患者死亡率的机器学习预测。
Sci Rep. 2020 Oct 30;10(1):18716. doi: 10.1038/s41598-020-75767-2.
2
Comparison and development of machine learning tools for the prediction of chronic obstructive pulmonary disease in the Chinese population.用于预测中国人群慢性阻塞性肺疾病的机器学习工具的比较与发展
J Transl Med. 2020 Mar 31;18(1):146. doi: 10.1186/s12967-020-02312-0.
3
Prognostic models for outcome prediction in patients with chronic obstructive pulmonary disease: systematic review and critical appraisal.
Development and validation of a nomogram for predicting COPD: A nationwide population-based study in South Korea.
开发和验证预测 COPD 的列线图:韩国全国基于人群的研究。
Medicine (Baltimore). 2024 Sep 27;103(39):e39901. doi: 10.1097/MD.0000000000039901.
4
Clinical Characteristics of Overweight Patients With Acute Exacerbation Chronic Obstructive Pulmonary Disease (AECOPD).超重的慢性阻塞性肺疾病急性加重(AECOPD)患者的临床特征。
Clin Respir J. 2024 Aug;18(8):e70001. doi: 10.1111/crj.70001.
5
The Impact of Different Smoking Behavior on Pulmonary Function and Pulmonary Hypertension Among Chinese Male Patients with Chronic Obstructive Pulmonary Disease.不同吸烟行为对中国男性慢性阻塞性肺疾病患者肺功能和肺动脉高压的影响。
Int J Chron Obstruct Pulmon Dis. 2024 Jun 14;19:1315-1331. doi: 10.2147/COPD.S455323. eCollection 2024.
6
Development and validation of nomogram including high altitude as a risk factor for COPD: A cross-sectional study based on Gansu population.高原作为 COPD 发病风险因素的列线图的构建和验证:一项基于甘肃人群的横断面研究。
Front Public Health. 2023 Mar 2;11:1127566. doi: 10.3389/fpubh.2023.1127566. eCollection 2023.
慢性阻塞性肺疾病患者结局预测的预后模型:系统评价和批判性评估。
BMJ. 2019 Oct 4;367:l5358. doi: 10.1136/bmj.l5358.
4
Global Strategy for the Diagnosis, Management, and Prevention of Chronic Obstructive Lung Disease: the GOLD science committee report 2019.全球慢性阻塞性肺疾病诊断、管理和预防策略:GOLD 科学委员会报告 2019.
Eur Respir J. 2019 May 18;53(5). doi: 10.1183/13993003.00164-2019. Print 2019 May.
5
Chronic obstructive pulmonary disease: a disease of old age?慢性阻塞性肺疾病:一种老年病?
J Glob Health. 2018 Dec;8(2):020306. doi: 10.7189/jogh.08.020306.
6
COPD Guidelines: A Review of the 2018 GOLD Report.COPD 指南:2018 GOLD 报告综述。
Mayo Clin Proc. 2018 Oct;93(10):1488-1502. doi: 10.1016/j.mayocp.2018.05.026.
7
The unmet global burden of COPD.慢性阻塞性肺疾病未被满足的全球负担。
Glob Health Epidemiol Genom. 2018 Apr 6;3:e4. doi: 10.1017/gheg.2018.1. eCollection 2018.
8
A machine learning approach to triaging patients with chronic obstructive pulmonary disease.一种用于慢性阻塞性肺疾病患者分诊的机器学习方法。
PLoS One. 2017 Nov 22;12(11):e0188532. doi: 10.1371/journal.pone.0188532. eCollection 2017.
9
Body weight and mortality in COPD: focus on the obesity paradox.慢性阻塞性肺疾病中的体重与死亡率:聚焦肥胖悖论
Eat Weight Disord. 2018 Feb;23(1):15-22. doi: 10.1007/s40519-017-0456-z. Epub 2017 Nov 6.
10
Comparison of World Health Organization and Asia-Pacific body mass index classifications in COPD patients.慢性阻塞性肺疾病患者中世界卫生组织与亚太地区体重指数分类的比较。
Int J Chron Obstruct Pulmon Dis. 2017 Aug 21;12:2465-2475. doi: 10.2147/COPD.S141295. eCollection 2017.